RxDoctor Payments Data

James Kurata

Optometrist · Los Angeles, CANPI 1629048798

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 33.8% of the total. 2025 is the largest year on record at $385, 2.1 times the $181 reported in 2019.

$1,694in general payments, 2019–2025

Across 73 payments — averaging $23.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$572
  • Alcon$525
  • Coopervision Inc.$216
  • Bausch & Lomb Americas Inc.$159
  • Tarsus Pharmaceuticals, Inc.$89
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$33
  • plus $99 from 5 others
$94,124in research payments, 2019–2025

Across 80 payments — averaging $1176.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$94K

What the payments were for

  • Food & beverage$1,694100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,694 in reported general payments places this provider in the 75th percentile of 6,778 optometrist providers in California.

See all optometrist providers in California

Medicare billing

Part B allowed, 2024
$8,509
Medicare patients
43
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →